Novo Integrated Sciences, Inc. (NASDAQ:NVOS) sees big growth in near-term interest

Novo Integrated Sciences, Inc. (NASDAQ:NVOS – Get Rating) saw a significant spike in short interest in March. As of March 31, there were short positions totaling 165,800 shares, up 325.1% from the March 15 total of 39,000 shares. Based on an average trading volume of 67,000 shares, the days-to-cover ratio is currently 2.5 days. About 1.9% of the stock’s shares are sold short.

NVOS opened at $2.30 on Friday. The company has a market cap of $66.00 million, a PE ratio of -10.00 and a beta of -0.24. Novo Integrated Sciences has a 12-month low of $1.02 and a 12-month high of $3.32. The company’s 50-day moving average price is $1.95 and its 200-day moving average price is $1.67. The company has a current ratio of 0.78, a quick ratio of 0.76 and a debt to equity ratio of 0.03.

Novo Integrated Sciences (NASDAQ:NVOS – Get Rating) last released its quarterly earnings results on Tuesday, January 18th. The company reported earnings per share of $0.06 for the quarter. The company had revenue of $3.16 million for the quarter. Novo Integrated Sciences had a negative return on equity of 13.07% and a negative net margin of 53.32%.

Major investors have recently bought and sold shares in the company. Citadel Advisors LLC acquired a new position in Novo Integrated Sciences valued at approximately $30,000 during the second quarter. Millennium Management LLC acquired a new position in Novo Integrated Sciences valued at approximately $111,000 during the second quarter. Finally, Morgan Stanley purchased a new position in Novo Integrated Sciences valued at approximately $288,000 during the second quarter. Institutional investors own 12.48% of the company’s shares.

About Novo Integrated Sciences (received rating)

Novo Integrated Sciences, Inc, along with its subsidiaries, provides multidisciplinary primary care products and services. It operates through two segments, healthcare services and product manufacturing and development. The company offers Physical Therapy, Chiropractic, Manual/Manipulative Therapy, Occupational Therapy, Elderly Care, Massage Therapy, Acupuncture and Functional Dry Needling, Podiatry, Stroke and Traumatic Brain Injury/Neurological Rehabilitation, Kinesiology, Vestibular Therapy, Concussion Management and Basic Testing, Trauma Sensitive Yoga and Meditation Concussion Brain Injuries and Work-Related Stress PTSD, Women’s Pelvic Health Program, Sports Medicine Therapy, Assistive Devices, Nutritionist, Holistic Nutrition, Fall Prevention Training, Sports Team Training Program and Private Personal Training Services.

See also

Receive news and reviews for Novo Integrated Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Novo Integrated Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.